Eric Walker added Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens to a number of topics

Eric Walker added 2019-07 FDA approval of imipenem/cilastatin plus relebactam and a number of links to Imipenem-cilastatin-relebactam, and added Imipenem-cilastatin-relebactam to New and investigational antibiotics and Imipenem-relebactam

Eric Walker added Imipenem-relebactam and Imipenem-Cilastatin-Relebactam: Imipenem Is Rele Back Again and Keith S. Kaye, MD, MPH: RESTORE-IMI 2 and Treating Critically Ill Patients With Respiratory Infections to Relebactam, and added Relebactam to New and investigational antibiotics and Beta-lactamase inhibitors

Eric Walker added Imipenem-cilastatin-relebactam and Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens to Imipenem-relebactam, and added Imipenem-relebactam to Relebactam and Imipenem

Eric Walker added Imipenem-cilastatin and Imipenem-relebactam and a number of links to Imipenem, and added Imipenem to Carbapenems